YUNGJIN PHARM. CO., LTD
003520 | KO
Overview
Corporate Details
- ISIN(s):
- KR7003520004
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 송파구 올림픽로35다길 13 국민연금 잠실사옥 2~3층, 송파구
- Website:
- https://eng.yungjin.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-28 00:00 |
Regulatory Filings
대규모기업집단현황공시[분기별공시(개별회사용)]
|
Korean | 6.1 KB | ||
| 2025-08-14 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 1.2 MB | ||
| 2025-08-14 00:00 |
Quarterly Report
[기재정정]분기보고서 (2025.03)
|
Korean | 695.0 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 879.7 KB | ||
| 2025-08-13 00:00 |
Environmental & Social Information
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
|
Korean | 11.1 KB | ||
| 2025-08-01 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-07-31 00:00 |
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 12.9 KB | ||
| 2025-07-25 00:00 |
Share Issue/Capital Change
[기재정정]신규시설투자등
|
Korean | 13.7 KB | ||
| 2025-05-30 00:00 |
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
|
Korean | 90.6 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 681.6 KB | ||
| 2025-05-07 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-03-28 00:00 |
AGM Information
정기주주총회결과
|
Korean | 33.7 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 11.7 KB | ||
| 2025-03-20 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.2 MB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 492.1 KB |
Automate Your Workflow. Get a real-time feed of all YUNGJIN PHARM. CO., LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for YUNGJIN PHARM. CO., LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for YUNGJIN PHARM. CO., LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing safer cell therapies for AL Amyloidosis and hematologic malignancies.
United States of America
IMMX
United States of America
IMMX
Develops biotech health products for disease prevention in dairy and beef cattle.
United States of America
ICCC
United States of America
ICCC
A biopharma firm developing immune checkpoint inhibitors for cancer immunotherapy.
South Korea
424870
South Korea
424870
Develops immunotherapies activating the immune system to fight cancer and infectious diseases.
United States of America
IBRX
United States of America
IBRX
Develops and supplies immunological reagents and diagnostics for research and drug discovery.
Japan
4570
Japan
4570
Pioneering TCR bispecific immunotherapies for cancer, infectious, and autoimmune diseases.
United States of America
IMCR
United States of America
IMCR
Develops targeted oncology therapies, like ADCs, for cancers with high unmet needs.
United States of America
IMNM
United States of America
IMNM
Develops oral antibodies from bovine colostrum for digestive and immune health.
United States of America
IMRN
United States of America
IMRN
Developing DNA-based immunotherapies for oncology and infectious diseases.
United States of America
IMNN
United States of America
IMNN
Clinical-stage biopharma developing gamma-delta T cell therapies for solid & hematological tumors.
United States of America
INAB
United States of America
INAB